Posts by: Ana Pamplona, PhD

Ana Pamplona, PhD

Ana holds her PhD in Biochemistry from the Faculty of Science and Technology from Lisbon (UNL). She has worked in the T-cell differentiation and Tumor targeting Lab at Instituto de Medicina Molecular, headed by Prof. Bruno Silva-Santos, and has served as a scientific reviewer for the peer-reviewed journal Infection & Immunity.

July 9, 2015July 9, 2015

New Drug Screening Technology Identifies Azoramide as an Anti-diabetic Compound

News

A new drug screening technology to identify new potential anti-diabetes compounds was developed by researchers at Harvard T.H. Chan School of Public Health, USA. The research, entitled “Phenotypic assays identify ... Read more

February 25, 2015February 25, 2015

Amyloidosis A Potential Link Between Type 2 Diabetes and Alzheimer’s Disease

News, Type 2 Diabetes News

Alzheimer disease (AD) and type 2 diabetes mellitus (T2D) are characterized by the presence of insoluble fibril deposits due to misfolded proteins (amyloids). A new study entitled “In Vivo Seeding and ... Read more

January 13, 2015January 13, 2015

Researchers Find That Hepatic Triglycerides in Type 2 Diabetes are Produced in Spite of Insulin Resistance

insulin resistance, News, Type 2 Diabetes News

A new study revealed that triglycerides can be produced in the liver independently of insulin action in the liver. The study, entitled “Insulin-independent regulation of hepatic triglyceride synthesis by fatty ... Read more

December 26, 2014December 26, 2014

Researchers Discover Polygonum Cuspidatum Extract as Diabetes Treatment

News

A new study on a potential Diabetes treatment entitled “Root of Polygonum cuspidatum extract reduces progression of diabetes-induced mesangial cell dysfunction via inhibition of platelet-derived growth factor-BB (PDGF-BB) and interaction ... Read more

December 19, 2014December 19, 2014

New Research Highlights Dehydration Issue in Diabetic Patients

News, Type 2 Diabetes News

A new study on the potential impact of Glucagon-Like Peptide-1 in Diabetes entitled “Endogenous Glucagon-Like Peptide-1 Reduces Drinking Behavior and Is Differentially Engaged by Water and Food Intakes in Rats” ... Read more

November 18, 2014November 18, 2014

New Neuregulin 4 Hormone Could Potentially Treat Obesity, Type 2 Diabetes, Liver Disease

News, Type 2 Diabetes News

A study describing a new potential treatment for metabolic disorders based on the brown fat hormone neuregulin 4 (Nrg4) entitled “The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through ... Read more

November 7, 2014November 7, 2014

Drug That Reversed Diabetes in Mice to be Tested on Humans

News

Researchers from the University of Alabama at Birmingham will begin a pioneering clinical trial in 2015 named “The repurposing of verapamil as a beta cell survival therapy in type 1 diabetes,” ... Read more

November 5, 2014November 5, 2014

Diabetes Patients Benefit From Medtronic Drug-Coated Balloon for Peripheral Artery Disease, According to Study

News, Type 2 Diabetes News

Medtronic Inc. recently developed an innovative experimental medical device, the IN.PACT Admiral drug-coated balloon for the treatment of peripheral artery disease in leg arteries above the knee, providing a promising treatment for patients ... Read more

October 30, 2014October 30, 2014

Higher Diabetes Rates Could Increase Tuberculosis Globally

News, Type 2 Diabetes News

The International Union Against Tuberculosis and Lung Disease is concerned about the increase of Diabetes incidences in countries where Tuberculosis (TB) is prevalent, since Diabetes increases the susceptibility for contracting the infection. Diabetes mellitus, ... Read more

October 20, 2014October 20, 2014

Those With Hypoglycemia, Diabetes To Benefit From First Predictive Low Glucose Management Technology

News, Type 2 Diabetes News

A critical step for the future development of an artificial pancreas for diabetics and hypogycemics has been launched by Medtronic, Inc. (NYSE:MDT). Medtronic, located in Minneapolis, just finished the first enrollment of ... Read more